Area of research
Cardiology and Cardiovascular Medicine · Pediatrics, Perinatology and Child Health
Research interest
Research interests include Chemotherapy-induced cardiotoxicity and mitigation, Cardiomyopathy and Myosin Studies, Childhood Cancer Survivors' Quality of Life, and HIV-related health complications and treatments.
Metabolic and Bariatric Surgery Utilization in the Era of Glucagon-Like Peptide-1 Receptor Agonists among Adolescents versus Adults
Progressive Left Ventricular Remodeling for Predicting Mortality in Children With Dilated Cardiomyopathy: The Pediatric Cardiomyopathy Registry
Dexrazoxane and Long-Term Heart Function in Survivors of Childhood Cancer
Multimodality Imaging for Cardiac Surveillance of Cancer Treatment in Children: Recommendations From the American Society of Echocardiography
Use of Metabolic and Bariatric Surgery Among US Youth
The genetic architecture of pediatric cardiomyopathy
Long-Term Outcomes after Adolescent Bariatric Surgery
Genetic Causes of Cardiomyopathy in Children: First Results From the Pediatric Cardiomyopathy Genes Study
Late health outcomes after dexrazoxane treatment: A report from the Children's Oncology Group
Strategies to prevent anthracycline-induced cardiotoxicity in cancer survivors
Upfront dexrazoxane for the reduction of anthracycline-induced cardiotoxicity in adults with preexisting cardiomyopathy and cancer: a consecutive case series
Effects of dexrazoxane on doxorubicin-related cardiotoxicity and second malignant neoplasms in children with osteosarcoma: a report from the Children’s Oncology Group
Left ventricular diastolic dysfunction in HIV-uninfected infants exposed in utero to antiretroviral therapy
Short- and long-term safety and efficacy of bariatric surgery for severely obese adolescents: a narrative review
No Obesity Paradox in Pediatric Patients With Dilated Cardiomyopathy
Cardiac and inflammatory biomarkers in perinatally HIV-infected and HIV-exposed uninfected children
Survival Without Cardiac Transplantation Among Children With Dilated Cardiomyopathy
Cardiac Effects of Highly Active Antiretroviral Therapy in Perinatally HIV-Infected Children
Exact Bayesian p-values for a test of independence in a 2 × 2 contingency table with missing data
Complete dexrazoxane cardioprotection for cardiac function but incomplete female cardioprotection for cardiac structure in doxorubicin-treated osteosarcoma survivors: Hearts too small for the body.
Global and National Burden of Diseases and Injuries Among Children and Adolescents Between 1990 and 2013
Impaired mitochondrial function is abrogated by dexrazoxane in doxorubicin‐treated childhood acute lymphoblastic leukemia survivors
Declining Incidence of Systolic Left Ventricular Dysfunction in Human Immunodeficiency Virus–Infected Individuals Treated With Highly Active Antiretroviral Therapy
Intravenous pegylated asparaginase versus intramuscular native Escherichia coli l-asparaginase in newly diagnosed childhood acute lymphoblastic leukaemia (DFCI 05-001): a randomised, open-label phase 3 trial
Cardiovascular Disease in Adult Survivors of Childhood Cancer
Lessons learned from the Pediatric Cardiomyopathy Registry (PCMR) Study Group
Health-Related Quality of Life and Functional Status Are Associated with Cardiac Status and Clinical Outcome in Children with Cardiomyopathy
Chronic kidney disease and cardiac morbidity — What are the possible links?